
|Articles|July 17, 2007
Update On Shelhigh/US Agreement
Shelhigh, Inc. has agreed to stop distributing its implantable medical devices, used in heart surgery and other procedures, until the company brings its production processes in line with Food and Drug Administration (FDA) standards [more].
Advertisement
Newsletter
Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
FDA expands antithrombin III (human) label to pediatric patients with rare blood-clotting disorder
2
Systemic Absorption and Dosing in Pediatric AD
3
Early genetic testing may reshape care for inherited connective tissue disorders in children
4
Roflumilast Efficacy and Safety in Pediatric AD
5












